Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Carboplatin/osimertinib/pemetrexed

Fever, diarrhoea and drug resistance: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hao L, et al. Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small-cell lung cancer. Thoracic Cancer 14 : 1036-1041, No. 11, Apr 2023. Available from: URL: http://doi.org/10.1111/1759-7714.14832 Hao L, et al. Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small-cell lung cancer. Thoracic Cancer 14 : 1036-1041, No. 11, Apr 2023. Available from: URL: http://​doi.​org/​10.​1111/​1759-7714.​14832
Metadaten
Titel
Carboplatin/osimertinib/pemetrexed
Fever, diarrhoea and drug resistance: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44928-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Sotalol